Cibc Private Wealth Group, LLC Ligand Pharmaceuticals Inc Transaction History

Cibc Private Wealth Group, LLC

$51.4 Billion
Q2 2024

A detailed history of Cibc Private Wealth Group, LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 160 shares of LGND stock, worth $16,504. This represents 0.0% of its overall portfolio holdings.

Number of Shares

160

Previous 160 -0.0%

Holding current value

$16,504

Previous $11,000 18.18%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$68.64 - $89.2 $10,982 - $14,272	160 New	160 $11,000
Q1 2022 May 16, 2022	SELL	$94.99 - $151.56 $1,614 - $2,576	-17 Reduced 0.14%	12,041 $1.36 Million
Q4 2021 Feb 08, 2022	SELL	$127.69 - $165.85 $14,812 - $19,238	-116 Reduced 0.95%	12,058 $1.86 Million
Q3 2021 Nov 12, 2021	SELL	$102.33 - $144.73 $197,394 - $279,184	-1,929 Reduced 13.68%	12,174 $1.7 Million
Q2 2021 Aug 16, 2021	SELL	$113.03 - $155.64 $3,390 - $4,669	-30 Reduced 0.21%	14,103 $1.85 Million
Q1 2021 May 12, 2021	BUY	$99.52 - $215.83 $95,937 - $208,060	964 Added 7.32%	14,133 $2.15 Million
Q4 2020 Feb 12, 2021	SELL	$80.55 - $106.05 $146,601 - $193,011	-1,820 Reduced 12.14%	13,169 $1.31 Million
Q3 2020 Nov 03, 2020	BUY	$89.56 - $126.72 $1.34 Million - $1.9 Million	14,989 New	14,989 $1.43 Million
Q3 2020 Oct 29, 2020	SELL	$89.56 - $126.72 $1.34 Million - $1.9 Million	-14,967 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$68.28 - $123.65 $312,107 - $565,204	-4,571 Reduced 23.4%	14,967 $1.67 Million
Q1 2020 May 15, 2020	SELL	$63.37 - $107.88 $178,830 - $304,437	-2,822 Reduced 12.62%	19,538 $1.42 Million
Q4 2019 Jan 30, 2020	SELL	$96.94 - $113.59 $4.54 Million - $5.32 Million	-46,793 Reduced 67.67%	22,360 $2.33 Million
Q3 2019 Oct 16, 2019	SELL	$86.25 - $120.16 $303,858 - $423,323	-3,523 Reduced 4.85%	69,153 $6.88 Million
Q2 2019 Jul 31, 2019	SELL	$107.38 - $129.34 $435,748 - $524,861	-4,058 Reduced 5.29%	72,676 $8.3 Million
Q1 2019 May 10, 2019	BUY	$105.93 - $142.47 $808,669 - $1.09 Million	7,634 Added 11.05%	76,734 $9.65 Million
Q4 2018 Feb 05, 2019	BUY	$128.36 - $272.13 $1.13 Million - $2.4 Million	8,823 Added 14.64%	69,100 $9.38 Million
Q3 2018 Nov 14, 2018	SELL	$211.18 - $274.49 $2.06 Million - $2.68 Million	-9,775 Reduced 13.95%	60,277 $16.5 Million
Q2 2018 Aug 02, 2018	SELL	$150.77 - $207.98 $11.7 Million - $16.2 Million	-77,933 Reduced 52.66%	70,052 $14.5 Million
Q1 2018 May 17, 2018	BUY	$138.63 - $182.62 $159,840 - $210,560	1,153 Added 0.79%	147,985 $24.4 Million
Q4 2017 Feb 12, 2018	BUY	$128.36 - $147.04 $384,181 - $440,090	2,993 Added 2.08%	146,832 $20.1 Million
Q3 2017 Nov 14, 2017	BUY	$120.91 - $137.94 $307,111 - $350,367	2,540 Added 1.8%	143,839 $19.6 Million
Q2 2017 Aug 09, 2017	BUY	N/A	141,299	141,299 $17.2 Million

Others Institutions Holding LGND

# of Institutions

247

Shares Held

17.5M

Call Options Held

61K

Put Options Held

7.8K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.74B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Private Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Private Wealth Group, LLC with notifications on news.

Account

Cibc Private Wealth Group, LLC Ligand Pharmaceuticals Inc Transaction History